Table 1 Characteristics of the BIRMA cancer patients at inclusion (March 2006)
From: Cancer and renal insufficiency results of the BIRMA study
General population ( n =1218) | Chemotherapy-naïve patients ( n =302) | Not chemotherapy-naïve patients ( n =916) | Comparison: chemotherapy-naïve vs not chemotherapy-naïve | |
|---|---|---|---|---|
Variables | Mean±s.d. | Mean±s.d. | Mean±s.d. | P -value |
Age (years) | 61.3±12.8 | 63.0±12.5 | 60.7±12.8 | 0.007 |
Weight (kg) | 69.6±14.8 | 69.6±15.7 | 69.6±14.5 | >0.05 |
Height (cm) | 166.1±9.1 | 167.5±9.0 | 165.7±9.1 | 0.01 |
Creatininemia (mg per 100 ml) | 0.94±0.52 | 0.96±0.74 | 0.92±0.42 | >0.05 |
aMDRD (ml min−1 per 1.73 m2) | 82.7±35.9 | 85.4±26.4 | 81.7±38.6 | 0.05 |
Hemoglobinemia (g per 100 ml) | 11.9±1.7 | 11.9±1.7 | 11.9±1.7 | >0.05 |
Hematocrit (%) | 35.8±4.9 | 35.3±4.9 | 36.0±4.9 | >0.05 |
Number of patients (%) | Number of patients (%) | Number of patients (%) | P -value | |
Bone metastasis | 396 (32.5) | 36 (11.9) | 360 (39.3) | <0.0001 |
Visceral metastasis | 463 (38.0) | 87 (28.8) | 376 (41.1) | 0.0001 |
Known kidney disease | 48 (3.9) | 20 (6.6) | 28 (3.1) | 0.006 |
Nephrectomy | 22 (1.8) | 3 (1.0) | 19 (2.1) | >0.05 |
